Trial intelligence / Profile preview

Tangshan Stroke Thrombolysis Registry

ChiCTR-OPC-15007046Phase 4Completed

Sponsor
Tangshan Gongren Hospital
Start
Jan 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Tangshan Gongren Hospital. Primary endpoints: symptomatic intracranial hemorrhage, 90-day mortality and 2 more. Started Jan 2006; status: completed.

02

Drugs

tissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on ChiCTR-OPC-15007046.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-15007046.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call